金陵药业：2025年半年度净利润约4833万元

Company Performance - Jinling Pharmaceutical reported a revenue of approximately 1.601 billion yuan for the first half of 2025, representing a year-on-year decrease of 6.62% [1] - The net profit attributable to shareholders of the listed company was approximately 48.33 million yuan, down 14.08% year-on-year [1] - The basic earnings per share were 0.0777 yuan, reflecting a year-on-year decline of 21.59% [1]